Investor directory

Dyadic International

Dyadic International is a biotechnology company based in Jupiter, Florida, with a research and development center in the Netherlands. The company focuses on the discovery, development, manufacture, and sale of enzymes and proteins for various industries, including bioenergy, bio-based chemicals, and biopharmaceuticals. Dyadic's core technology is its patented C1 fungus, which enables the efficient production of industrial enzymes and proteins at scale. This platform allows for the discovery of novel genes and proteins and has been licensed to several third parties, including Abengoa Bioenergy, BASF, and Codexis, for non-pharmaceutical applications. Dyadic seeks to maximize the value of its technologies through licensing arrangements and collaborations, providing partners with the ability to manufacture and utilize the enzymes produced through its innovative processes.
http://dyadic.com
https://crunchbase.com/organization/dyadic-international
https://facebook.com/dyadicintl
https://linkedin.com/company/dyadic-international-inc.
https://pitchbook.com/profiles/company/41554-09
https://twitter.com/dyadic_intl
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=4272801

Mark A. Emalfarb

Founder, Chairman and CEO

2 past transactions

VLPbio

Seed Round in 2018
VLPbio is a biotechnology company dedicated to the research and development of chimeric virus-like particles (VLPs) for use as vaccines in both human and animal health. The company specializes in creating innovative prophylactic and therapeutic vaccines through its proprietary antigen-display nanoplatforms. By leveraging its patented technology, VLPbio aims to provide immunotherapeutic solutions that address significant unmet medical needs in the treatment of cancer and infectious diseases. Its focus on developing effective vaccines positions VLPbio as a key player in the biopharmaceutical industry, contributing to advancements in healthcare for both humans and animals.

BDi Biotechnology Group

Seed Round in 2018
BDi Biotechnology Group Specialized in contract research management services. A biotechnology customer-centric company with strong background, providing solutions in health and food sectors. It provide services helping their clients with a high level of flexibility, cost oriented, open communication, reliability and confidentiality. They also provide products thanks to their own antigen display technology with a strong potential to boost and direct specific immune responses, humoral or cellular depending on the construct.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.